PlainRecalls
FDA Devices Moderate Class II Completed

LVP software of the Ivenix Infusion System (IIS); LVP-SW-0004

Reported: March 20, 2024 Initiated: May 10, 2023 #Z-1283-2024

Product Description

LVP software of the Ivenix Infusion System (IIS); LVP-SW-0004

Reason for Recall

Retroactively reported corrections from 2023: 1) A software defect may cause an incorrect (Fail-Stop) alarm when an administration set is loaded or coupled while the pump is executing the power-up sequence. May lead to delay in therapy. 2) Alert is not annunciated informing the clinician that the bolus cannot be delivered when the entered bolus dose exceeds the Care Profile Hard Rate Max limit and Rapid Bolus is selected. May lead to over infusion. Both issues were resolved in all fielded product in software version 5.8.0, which was installed in affected units May thru August 2023.

Details

Recalling Firm
Fresenius Kabi USA, LLC
Units Affected
6 US
Distribution
US Nationwide distribution to the states of CA, CO, NJ, WI, UT.
Location
North Andover, MA

Frequently Asked Questions

What product was recalled?
LVP software of the Ivenix Infusion System (IIS); LVP-SW-0004. Recalled by Fresenius Kabi USA, LLC. Units affected: 6 US.
Why was this product recalled?
Retroactively reported corrections from 2023: 1) A software defect may cause an incorrect (Fail-Stop) alarm when an administration set is loaded or coupled while the pump is executing the power-up sequence. May lead to delay in therapy. 2) Alert is not annunciated informing the clinician that the bolus cannot be delivered when the entered bolus dose exceeds the Care Profile Hard Rate Max limit and Rapid Bolus is selected. May lead to over infusion. Both issues were resolved in all fielded product in software version 5.8.0, which was installed in affected units May thru August 2023.
Which agency issued this recall?
This recall was issued by the FDA Devices on March 20, 2024. Severity: Moderate. Recall number: Z-1283-2024.